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To assess the adequacy of medical prescriptions for community-acquired pneumonia at
the  emergency department of the Hospital de Clínicas de Porto Alegre, we conducted a
prospective cohort study, from January through April 2011. All patients with suspected pneu-
monia were selected from the ﬁrst prescription of antimicrobials held in the emergency
room.  Patients with a description of pneumonia, community-acquired pneumonia, respi-
ratory  infection, or other issues related to community-acquired pneumonia were selected
for  review. Two-hundred and ﬁfteen patients were studied. Adherence to the hospital care
protocol  was: 11.2% for the initial recommended tests (chest X-ray and collection of sputum
sample),  34.4% for blood cultures, and 92.1% for the antimicrobial choice. Sixty percent of
the prescriptions consisted of a combination of drugs, and the association of beta-lactam
and  macrolide was the most common. The Hospital Infection Control Committee evaluated
patients’  prescriptions within a median time of 23.5 h (IQR 25–75%, 8–24). Negative eval-
uations  accounted for 10% of prescriptions (n = 59). Fourteen percent of the patients died
during  hospitalization. In the multivariate analysis, Pneumonia Severity Index Score and use
of ampicillin + sulbactam alone were independently related to in-hospital mortality. Therewas  a high adherence to the hospital’s CAP protocol, in relation to antimicrobial choice.
Severity  score and use of ampicillin + sulbactam alone were independently associated to
in-hospital death.
© 2013 Elsevier Editora Ltda.  Este é um artigo Open Access sob a licença de CC BY-NC-NDntroduction
ommunity-acquired pneumonia (CAP) is an acute infec-
ion  that affects the lower respiratory tract, which occurs in
atients  outside the hospital or develops within the ﬁrst 48 h
fter hospital admission.1 Often this diagnosis is made-up by a
ombination of clinical symptoms of acute respiratory disease,
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Este é um artigo Open Access sob a licençalaboratory tests, microbiological ﬁndings, response to antimi-
crobial  therapy and especially, by chest X-ray alone, despite
the  low sensitivity and speciﬁcity of this test for pneumonia
diagnosis.2
Worldwide incidence of pneumonia is 12 cases/1000 inha-o Barcelos, 2350, Porto Alegre, RS 90035-903, Brazil.
bitants  per year. Pneumonia represents the leading cause
of  death from infectious disease, despite all the advances
in  medicine over the years, such as, the availability of new
 de CC BY-NC-ND
i s . 2 0512  b r a z j i n f e c t d 
antibiotics and effective vaccines.3 In Brazil, in 2009, of the
total  admissions for respiratory diseases, 52.0% were  for pneu-
monia,  representing 7.3% of total admissions in the country.4
There are several clinical scores designed to stratify
patients, regarding severity and mortality due to CAP, includ-
ing  the Pneumonia Score Index (PSI). The PSI assigns points
based  on age, comorbidities and abnormalities in the physi-
cal  examination. This score classiﬁes pneumonia patients into
ﬁve  groups, in increasing order of severity and death risk over
the  next 30 days.1,5 In the Hospital de Clínicas de Porto Alegre
(HCPA)  there is a clinical care guideline for patients with CAP,
based  on the PSI, which serves as a decision making tool for
processing  whether individuals can be managed on an outpa-
tient  basis or require hospitalization.6 Besides, an infection
control committee evaluates antibiotic prescriptions and is
available seven-days a week for antimicrobial consultation.
The  objective of this study was  to assess the management
adequacy of patients with CAP according to local guidelines
and  recommendations from the hospital infection control
committee.
Materials  and  methods
Setting
The Hospital de Clinicas de Porto Alegre is the teaching hospi-
tal  of the Universidade Federal do Rio Grande do Sul (UFRGS).
With  795 beds for 67 medical specialties, it provides assistance,
education and health research. The hospital has an adult pub-
lic  emergency department with 49 beds that receives patients
24  h a day. Patients treated in the emergency department are
predominantly from Porto Alegre (56.0%), from the surround-
ing  area (32.0%), and from other parts of the state (12.0%).
The  HCPA has an infection control committee (ICC) com-
posed  of six physicians, four nurses, one pharmacist, two
resident  pharmacists, two resident nurses, as well as 10
trainees  who  are nursing and pharmacy graduates fellows. In
the hospital’s antimicrobial panel, 70% of the selected antimi-
crobials  need a physician ﬁlled order for prescription, which
are  then analyzed by the ICC. The ICC’s evaluations are con-
ducted  Monday through Friday during business hours.
Study  design  and  deﬁnitions
We  conducted a prospective cohort study of patients with CAP
from January 20th until April 20th, 2011. All patients were
selected  from the antibiotic order forms, included in the sys-
tem  by the emergency department. Patients with suspected
pneumonia, CAP, respiratory infection, or any other justiﬁca-
tion  related to CAP were  included for review.
The study included adult patients, over 18 years of age,
without immuno-suppression (i.e. transplanted patients or
HIV/AIDS patients), admitted in less than 48 h to the emer-
gency  department and, had not used antimicrobials prior to
admission.
Patients were  selected according to the antimicrobial order
forms  included in the institution’s database. This way,  patients
taking  antibiotics not evaluated by the ICC team, such as
amoxicillin,  ampicillin, doxycycline, and erythromycin, were
not  included in the study. 1 3;1  7(5):511–515
We  reviewed the demographic characteristics of the
patients, age and gender, previous comorbidities, antimi-
crobial  choice, evaluations conducted by the ICC team, PSI
classiﬁcation, and adequacy of prescription, according to local
care  guidelines.
Adherence to the care protocol was stratiﬁed into three
steps:  step 1 – request for a chest X-ray and sputum analysis;
step  2: request for blood culture; step 3: antimicrobial choice.
The  Infection Control Committee evaluations were  divided
into:  positive evaluations – prescription approved; prescrip-
tion  approved with restriction of time; approved until culture
results;  recommendation for route change; and evaluations
considered negative – not approved, pending further informa-
tion,  and recommendation for changing antimicrobial choice.
All  enrolled patients were followed-up at the hospital until
the  outcome: either discharge from the institution or death.
This  investigation was conducted in accordance with the
“Guidelines and Norms Regulating Research Involving Human
Subjects”  adopted by the National Health Council in its Res-
olution  196/96 and approved by the Ethics Committee of
Research  of the HCPA, accredited by the National Commission
on  Research Ethics under number 10-0468.
Statistical  analysis
To determine the distribution pattern of the variables, the
Kolmogorov–Smirnov test was  used. Variables with skewed
distribution were presented as medians and interquartile
ranges (IQR). Differences between variables were  expressed
as  odds ratios and 95% conﬁdence intervals. A p < 0.05 value
was  considered statistically signiﬁcant. To investigate the rela-
tionship between speciﬁc variables and the in-hospital death
outcome,  logistic regression analysis was  performed using
backward  step method. The data were compiled in Microsoft
Excel® and analyzed with the Statistical Package for Social
Science  (SPSS), version 18.0.
Results
Two hundred and seventy-eight patients were  included. Of
these,  58 patients presented changes to the initial diagnosis of
CAP:  urinary tract infection, asthma, or bronchitis, and were,
therefore,  excluded from the study. From the 220 remaining
patients, there was  a loss to follow-up of 5 patients; four due to
desertion from the emergency department, and one patient’s
data  were lost in the database. Therefore, we  included 215
patients  in the ﬁnal analysis.
Patients’  demographic characteristics are shown in Table 1.
Adherence  to the local care guidelines was 11.2% for step
1,  34.4% for step 2, 92.1% for step 3, and 1.9% for the full guide-
line.  All patients (n = 215) had a chest X-ray requested, 37.7%
(n  = 81) blood culture, 25.1% (n = 54) microbiology of sputum,
and  13.5% (n = 29) had the acid-fast bacilli exam requested.
Out  of 81 blood cultures, 10 (12.3%) were positive. Among the
microorganisms found, the most prevalent were:  Streptococcus
pneumoniae (n = 3), Klebsiella pneumoniae (n = 2), Gram posi-
tive  bacilli (n = 1), Escherichia coli (n = 1), Pseudomonas aeruginosa
(n  = 1), Enterococcus spp. (n = 1) and Staphylococcus aureus (n = 1).
In  the sputum culture results, there were six outstanding
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Table 1 – Demographic characteristics and comorbidities
of  patients with community-acquired pneumonia at the
HCPA,  January–April 2011.
Patients n = 215
Age (median, IQR) 67 (58–77)
60  years old or more 155 (72.1)
Female 119 (55.3)
Comorbidities
Cardiovascular disease 110 (51.2)
Diabetes 54 (25.1)
COPD  53 (24.7)
Cancer 45 (20.9)
Severity score
PSI  1 15 (7)
PSI  2 24 (11.2)
PSI  3 54 (25.1)
PSI  4 108 (50.2)
PSI  5 14 (6.5)
Hospitalization days (median, IQR) 8 (4–17)
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Table 2 – Antimicrobial therapy in patients with
community-acquired pneumonia at the HCPA,
January–April 2011.
Therapy n (%)
Two or more antimicrobial classes 130 (60.5)
Beta-lactam/macrolide 115 (53.5)
Beta-lactam/clindamycin 7 (3.2)
Beta-lactam/macrolide/clindamycin 4 (1.8)
Othersa 4 (1.8)
Single class 85 (39.5)
Beta-lactam 82 (38.1)
Quinolone 2 (0.9)
Macrolide 1 (0.4)
a Others: beta-lactam/quinolone; macrolide/clindamycin; beta-
lactam/macrolide/quinolone.
Table 3 – Infection Control Committee evaluation of the
ﬁrst  antimicrobial prescription in patients with
community-acquired pneumonia at the HCPA,
January–April 2011.
Overall ICC evaluations 597 (100)
Positive evaluations 538 (90.2)
Approved 240 (40.2)
Approved with restriction of time 77 (12.8)
Approved until culture results 122 (20.4)
Switch to oral therapy 99 (16.5)
Negative evaluations 59 (9.8)
More information needed 32 (5.3)
Another option suggested 23 (3.8)
Not  approved 4 (0.6)
Time for evaluation in hours (median, IQR) 23.5 (8–24)
Number of evaluations per patient (median, IQR) 3 (2–4)
Length of time approved, in days (median, IQR) 3  (3–5)
IQR, interquartile range.
F
JData are n (%) of patients, unless otherwise indicated. IQR,
interquartile range; COPD, chronic obstructive pulmonary disease.
trains: one P. aeruginosa, one S. aureus, one S. pneumoniae, one
lebsiella  spp. and two Candida spp.
All patients underwent a diagnostic X-ray. Radiological
hanges in 47.4% (n = 102) of the patients showed consolida-
ion,  in 19.5% (n = 42) inﬁltrates, in 6.5% (n = 14) pleural effusion,
nd  in 8.4% (n = 18) other results. In 9.3% (n = 20) of cases, the
-ray  was  normal, and in 8.8% (n = 19) there were  no results
eported in the system.
The  distribution of patients, by risk stratiﬁcation, according
o  the PSI score was: PSI 1 (7%, n = 15), PSI 2 (11.2%, n = 24), PSI 3
25.1%,  n = 54), PSI 4 (50.2%, n = 108) and PSI 5 (6.5%, n = 14). The
edian  hospital stay was  8 days (IQR 25–75%, 4–17) and their
tratiﬁcation, according to the severity score index, is shown
n  Fig. 1.
The  antibiotics chosen as ﬁrst-line therapy were  the com-
ination  of cefuroxime and azithromycin in 40% (n = 86) of
ases,  followed by ampicillin + sulbactam in 12.6% (n = 27),
efuroxime  in 10.7% (n = 23) and a combination of ampi-
illin  + sulbactam plus azithromycin in 4.7% (n = 10). Sixty
ercent  (n = 130) of patients were treated with a combination
f  two or more  drugs (Table 2).
The ICC made a median of three evaluations per
atient, corresponding to 596 recommendations for the ﬁrst
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anuary–April 2011.Data  are n (%) of ICC evaluations, unless otherwise indicated.
antimicrobial adopted. The median time, from prescription
until evaluation, was 23.5 h (IQR 25–75%, 8–24). Negative eval-
uations  accounted for 9.8% (n = 59) of the ﬁrst antimicrobial
prescribed. The median length of time of antimicrobial use,
approved  by the ICC team, was  3 days (IQR 25–75%, 3–5) –
Table  3.Fourteen percent of patients (n = 31) died during hospi-
talization. Of these, 38% had cancer and 38% suffered from
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Fig. 2 – In-hospital mortality associated with risk score index (PSI) in patients with community-acquired pneumonia at the
HCPA, January–April 2011.
cardiovascular disease. The association between mortality
and  the severity score is shown in Fig. 2.
In multivariate analysis, the severity score and the
use  of ampicillin + sulbactam were independent predictors
of  in-hospital mortality (Table 4). Variables selected for
multivariate analysis, based on the signiﬁcance on univari-
ate  analysis were:  use of ampicillin + sulbactam, cefurox-
ime  + azithromycin, ampicillin + sulbactam + azithromycin, an
association of two or more  classes of antimicrobials and the
PSI  score.
Discussion
There was  poor adherence to local guidelines except for
antimicrobial choice. Most patients had high PSI. The ICC
team’s  evaluation, related to antimicrobial choice, was  mostly
positive,  and the treatment of choice, with two or more  classes
of  antimicrobials, prevailed. The in-hospital mortality was
14%,  similar to other centers. Ampicillin + sulbactam and high
PSI  scores were  independently related to in-hospital mortality.
In  a prospective study involving patients who were hos-
pitalized  for CAP in Brazil the average patients age was  65
and  patients more  than 60 years old accounted for 67% of the
7sample. In the United States, an observational study showed
that  59% of hospitalized patients with CAP, were 65 years old or
more. Cardiovascular diseases (43%) and respiratory illnesses
(34%)  were  the most prevalent comorbidities.8
Table 4 – Multivariate risk analysis of factors associated with in
pneumonia at the HCPA, January–April 2011.
HR 
Ampicilin/sulbactam 5.186 
Cefuroxime + azithromycin 1.731 
Ampicilin/sulbactam + azithromycin 1.331 
Combination therapy 0.464 
PSI score 2.346 
Variables selected for multivariate analysis were those with p < 0.05
ime  + azithromycin, ampicillin + sulbactam + azithromycin, an associationIn our study, the PSI indicates a population that required
hospitalization: brief hospitalization in 25% (PSI 3), prolonged
hospitalization in 56% (PSI 4 an 5). On the other hand, patients
classiﬁed  as PSI 1 and 2, who should be discharged, were
treated  as in-patients 90% of the time, with a median stay of
around  6–7 days. In a study at the HCPA in 2005, 24% of the
patients  who attended the emergency for CAP had a PSI score
of  3, 29% had a PSI of 4, and 14% had a PSI of 5. In this study,
70%  of the population with a PSI of 1 or 2 was  treated as in-
patients.9 A prospective study in Chile, in immunocompetent
patients with CAP, 23% had a PSI of 3, 38% PSI 4, and 17% had
a  PSI of 5.10 Our results show a greater proportion of patients
with  increased mortality risk (PSI 4 and 5), indicating a need
for  long hospital stays. However, most patients with low risk
scores  were treated as in-patients, increasing the risks related
to  hospital infection to these patients, costs to the health sys-
tem,  and overcrowding of the emergency department. The
reasons  for these hospitalizations were  not reviewed.
The rate of adherence to local guidelines regarding blood
cultures, recommended by international guidelines, was  low.
However blood culture tests, when requested, obtained neg-
ative  results in most cases, and when a microorganism was
identiﬁed  it did not change the patient’s therapy. Moreover, in
spite of the low rate of positive culture results, in both blood
and  sputum cultures, there was no relation between the bacte-
ria  identiﬁed in sputum and those identiﬁed in blood cultures.
In  a study of CAP patients, blood cultures were  positive
in  less than 20% of cases.11 A Canadian study found that
-hospital mortality in patients with community-acquired
IC 95% p
1.712–15.711 0.004
0.341–8.786 0.508
0.102–17.37 0.828
0.09–2.388 0.358
1.302–4.225 0.005
 in univariate analysis: use of ampicillin + sulbactam, cefurox-
 of two or more antimicrobial classes and the PSI severity score.
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he contribution of blood cultures for clinical management
f  patients with CAP was  low. Only 5% of blood cultures
ere  positive in immunocompetent patients and the clinical
valuation  was  more  decisive than the test results to deter-
ine  treatment.12 The Brazilian guidelines recommend that
lood  cultures should be collected in critically ill patients
ho  do not respond to antimicrobial therapy.1 Although most
nternational  guidelines recommend this test for in-patient
anagement, based on our results, we must review this rec-
mmendation in our local guidelines.
Adherence to clinical guidelines is a difﬁcult task. Adher-
nce  to the recommended chest X-ray examination and
ntimicrobial choice was  high. The X-ray is essential for the
iagnosis  of pneumonia, helps in the severity assessment,1
nd it is easy to perform in our setting. The high adherence to
ntimicrobial choice recommended by the HCPA is a reﬂection
f  the ICC team’s work. The ICC team evaluates more  than 150
rescriptions daily. Therefore the ICC continuously reinforces
ocal  protocols recommendations.
The  mortality of patients hospitalized for CAP can vary
rom  5.7 to 14%.13 The mortality associated with the sever-
ty  score in our study was  greater than that in the study that
alidated  the PSI. In this study risk of death for PSI Classes
 and 5 were  8% and 29%, respectively.5 In our study 17% of
atients  in the PSI 4 score group died, and 42% of patients in
he  PSI 5 class, died during hospital admission.
For empirical antimicrobial therapy, national and inter-
ational guidelines recommend the use of a combination
herapy with a beta-lactam and a macrolide or ﬂuroquinolone
or  patients requiring hospitalization.1,3,14 A study evaluat-
ng  the impact of therapy on mortality suggests superiority
f  beta-lactam antibiotics associated with a macrolide com-
ared  with beta-lactam monotherapy on 14-day mortality
n  patients with severe CAP.15 Our study demonstrates the
redominant use of empirical therapy with an association
etween beta-lactam antibiotics and macrolides, with a higher
ortality  in patients who received single therapy of ampi-
illin  + sulbactam in the logistic regression analysis, which is
n accordance with national and international guidelines.
Our  study has limitations. This is a single center study,
hich limits the generalization of the results. Patients who
sed  antimicrobials that were  not evaluated by the IC team
ere  not included. Factors that may  be related to mortality,
uch  as the timing for initiation of antimicrobial therapy or
ose  of antibiotics prescribed, were  not evaluated. However,
he  results of high adherence to prescription recommenda-
ions, in response to daily IC team evaluations, can serve as
 model of the protocol’s successful management. Protocol
ecommendations must be systematically reinforced to guar-
ntee  physicians compliance.
In  conclusion, most patients with pneumonia were classi-
ed  as having moderate to severe infections. High adherence
o  the Protocol was  found regarding antimicrobial choice,
nd  X-ray performance, but poor adherence to blood cul-
ure  exams. The use of ampicillin + sulbactam, without a
acrolide,  was  associated with higher mortality. There is a
eed for a pneumonia protocol review in our setting and this
ork  might contribute to changes in this local protocol. We
tress  the importance of local data to guide decision-making3;1 7(5):511–515  515
recommending protocols.
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